Dementia treatment for Alzheimer-type

Dementia treatment for Alzheimer-type

• A. Psychosis (olanzapine, quetiapine), inappropriate sexual behavior, visual hallucinations refractory to donepezil
• B. Lewy Body dementia treatment
• C. Quetiapine, olanzapine, risperidone
• D. Tardive dyskinesia treatment

Answer: (A)

In Alzheimer-type dementia, managing persistent behavioral and psychotic symptoms often requires adding atypical antipsychotics when a cholinesterase inhibitor like donepezil isn’t controlling the problems. Antipsychotics such as olanzapine or quetiapine can help reduce psychosis, visual hallucinations, and disinhibitory behaviors (like inappropriate sexual behavior), improving safety and daily functioning when symptoms remain refractory to donepezil. This approach is used specifically for Alzheimer-type dementia because it targets neuropsychiatric symptoms that frequently accompany the disease. Treating Lewy Body dementia with the same strategy isn’t appropriate, since this condition often reacts differently to antipsychotics and can worsen motor symptoms. Tardive dyskinesia treatment isn’t a dementia treatment strategy, and listing multiple antipsychotics without tying them to a refractory psychiatric presentation doesn’t capture the targeted scenario described here.

In Alzheimer-type dementia, managing persistent behavioral and psychotic symptoms often requires adding atypical antipsychotics when a cholinesterase inhibitor like donepezil isn’t controlling the problems. Antipsychotics such as olanzapine or quetiapine can help reduce psychosis, visual hallucinations, and disinhibitory behaviors (like inappropriate sexual behavior), improving safety and daily functioning when symptoms remain refractory to donepezil. This approach is used specifically for Alzheimer-type dementia because it targets neuropsychiatric symptoms that frequently accompany the disease.

Treating Lewy Body dementia with the same strategy isn’t appropriate, since this condition often reacts differently to antipsychotics and can worsen motor symptoms. Tardive dyskinesia treatment isn’t a dementia treatment strategy, and listing multiple antipsychotics without tying them to a refractory psychiatric presentation doesn’t capture the targeted scenario described here.